These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8588693)

  • 1. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.
    Greiff L; Andersson M; Svensson C; Nilsson M; Erjefält I; Erjefält JS; Persson CG
    Allergy; 1995 Jul; 50(7):593-7. PubMed ID: 8588693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
    Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
    Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L; Andersson M; Svensson C; Persson CG
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways.
    Svensson C; Pipkorn U; Alkner U; Baumgarten CR; Persson CG
    Clin Exp Allergy; 1992 Mar; 22(3):411-6. PubMed ID: 1586878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotine on the human nasal mucosa.
    Greiff L; Wollmer P; Erjefält I; Andersson M; Pipkorn U; Persson CG
    Thorax; 1993 Jun; 48(6):651-5. PubMed ID: 8346498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of experimental changes in nasal airway pressure on mucosal output of plasma.
    Berg S; Wollmer P; Andersson M; Persson CG; Greiff L
    Clin Physiol Funct Imaging; 2003 May; 23(3):155-8. PubMed ID: 12752558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenge-induced plasma exudation and mucinous secretion in human airways.
    Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG
    Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis.
    Svensson C; Andersson M; Greiff L; Alkner U; Persson CG
    Clin Exp Allergy; 1995 Oct; 25(10):942-50. PubMed ID: 8556565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "nasal pool"-device for challenge and lavage of the nasal mucosa in children: histamine-induced plasma exudation responses.
    Greiff L; Meyer P; Svensson C; Persson CG; Andersson M
    Pediatr Allergy Immunol; 1997 Aug; 8(3):137-42. PubMed ID: 9532254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
    Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal mucosal endorgan hyperresponsiveness.
    Svensson C; Andersson M; Greiff L; Persson CG
    Am J Rhinol; 1998; 12(1):37-43. PubMed ID: 9513658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.
    Svensson C; Baumgarten CR; Pipkorn U; Alkner U; Persson CG
    Thorax; 1989 Jan; 44(1):13-8. PubMed ID: 2648641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.
    Greiff L; Pipkorn U; Alkner U; Persson CG
    Clin Exp Allergy; 1990 May; 20(3):253-9. PubMed ID: 2364306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
    Greiff L; Persson CG; Svensson C; Enander I; Andersson M
    J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical capsaicin in seasonal allergic rhinitis.
    Greiff L; Svensson C; Andersson M; Persson CG
    Thorax; 1995 Mar; 50(3):225-9. PubMed ID: 7660332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids may not inhibit plasma exudation by direct vascular antipermeability effects in human airways.
    Greiff L; Andersson M; Svensson C; Alkner U; Persson CG
    Eur Respir J; 1994 Jun; 7(6):1120-4. PubMed ID: 7925882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine-induced airway mucosal exudation of bulk plasma and plasma-derived mediators is not inhibited by intravenous bronchodilators.
    Svensson C; Alkner U; Pipkorn U; Persson CG
    Eur J Clin Pharmacol; 1994; 46(1):59-65. PubMed ID: 8005188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of size-selectivity at histamine-induced exudation of plasma proteins in atopic nasal airways.
    Greiff L; Andersson M; Erjefält JS; Svensson C; Persson CG
    Clin Physiol Funct Imaging; 2002 Jan; 22(1):28-31. PubMed ID: 12003096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo.
    Greiff L; Andersson M; Wollmer P; Persson CG
    Eur Respir J; 2003 Feb; 21(2):308-12. PubMed ID: 12608446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.
    Greiff L; Andersson M; Akerlund A; Wollmer P; Svensson C; Alkner U; Persson CG
    Thorax; 1994 Feb; 49(2):121-7. PubMed ID: 8128400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.